Instant Insights The Prescription Drug Problem & PBM Reform

One provision would keep PBMs from steering enrollees toward their mail-order pharmacies.

The PBM industry is currently experiencing a confluence of technological, regulatory, and marketplace changes that will impact PBMs that operate with opaque business practices and antiquated technology.

Rep. Nick Langworthy asked about duty of care at a committee hearing featuring three top PBM executives.

Viking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.

But a rating agency expects the new weight loss drugs to reduce spending on bariatric surgery.

But the new GLP-1 agonist obesity and diabetes fighters took up more rungs on Milliman's list of top cash eaters.

The Wells Fargo plan paid almost $10,000 for a generic pill for multiple sclerosis that Wegmans pharmacies sold for $648, according to the complaint, driving up premiums and out-of-pocket costs.